In Gardasil: Fast-Tracked and Flawed, the author argues that there is no evidence of how much cervical cancer the HPV vaccine will prevent. What is emerging, however, is evidence of its harmful effects. In the nine years since the experimental HPV vaccination program began, there have been 255 deaths worldwide and 43,000 adverse events. Gardasil was fast-tracked through the FDA, a process usually reserved for serious diseases where a new drug is required to fill an unmet and urgent medical need. Yet the incidence of cervical cancer had been markedly in decline due to Pap smear programs. This in-depth investigation of the approval of a vaccine exposes the cracks in the pharmaceutical industry and highlights the problems that arise when government regulators and corporate interests are prioritized ahead of patient safety and independent science

Mode of access: World Wide Web